BR9608019A - Uma nova proteína e um processo para a preparação da mesma' - Google Patents
Uma nova proteína e um processo para a preparação da mesma'Info
- Publication number
- BR9608019A BR9608019A BR9608019-1A BR9608019A BR9608019A BR 9608019 A BR9608019 A BR 9608019A BR 9608019 A BR9608019 A BR 9608019A BR 9608019 A BR9608019 A BR 9608019A
- Authority
- BR
- Brazil
- Prior art keywords
- protein
- dimer
- seq
- purifying
- amino acid
- Prior art date
Links
- 102000004169 proteins and genes Human genes 0.000 title abstract 9
- 108090000623 proteins and genes Proteins 0.000 title abstract 9
- 238000004519 manufacturing process Methods 0.000 title 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 2
- 239000000539 dimer Substances 0.000 abstract 2
- 239000000710 homodimer Substances 0.000 abstract 2
- 239000000178 monomer Substances 0.000 abstract 2
- 239000013612 plasmid Substances 0.000 abstract 2
- 208000020084 Bone disease Diseases 0.000 abstract 1
- 241000588724 Escherichia coli Species 0.000 abstract 1
- 210000000845 cartilage Anatomy 0.000 abstract 1
- 208000015100 cartilage disease Diseases 0.000 abstract 1
- 238000012258 culturing Methods 0.000 abstract 1
- 210000003000 inclusion body Anatomy 0.000 abstract 1
- 229930182817 methionine Natural products 0.000 abstract 1
- 125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000003381 solubilizing effect Effects 0.000 abstract 1
- 230000009466 transformation Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Patente de Invenção: <B>"UMA NOVA PROTEìNA E UM PROCESSO PARA A PREPARAçãO DA MESMA"<D>. Uma proteína tendo uma seq³ência de amino-ácidos na SEQ ID No. : 1 da Relação das Seq³ências, derivada da MP 52 humana, e uma proteína dímera da mesma. Uma proteína homo-dímera descrita acima pode ser obtida pela construção de um plasmídio que contem um DNA codificando uma seq³ência de amino - ácidos, na SEQ ID No. : 1 da Relação das Seq³ências com uma metionina no terminal - N, introduzindo o plasmídio no interior de uma E. coli para transformação, solubilizando os corpos de inclusão que foram obtidos pela cultivação do transformante, purificando a proteína monómera a partir da solução solubilizada, redobrando a proteína monómera em uma proteína dímera e purificando a mesma. A proteína homo-dímera descrita acima é útil como uma composição farmacêutica pata o tratamento das doenças das cartilagens e dos ossos.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9366495 | 1995-04-19 | ||
| JP32240395 | 1995-11-17 | ||
| PCT/JP1996/001062 WO1996033215A1 (en) | 1995-04-19 | 1996-04-19 | Novel protein and process for producing the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9608019A true BR9608019A (pt) | 1999-11-30 |
Family
ID=26434967
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9608019-1A BR9608019A (pt) | 1995-04-19 | 1996-04-19 | Uma nova proteína e um processo para a preparação da mesma' |
Country Status (18)
| Country | Link |
|---|---|
| US (3) | US7235527B2 (pt) |
| EP (1) | EP0955313B1 (pt) |
| AT (1) | ATE325131T1 (pt) |
| AU (1) | AU704515C (pt) |
| BR (1) | BR9608019A (pt) |
| CA (1) | CA2216741C (pt) |
| DE (2) | DE69636728T4 (pt) |
| DK (1) | DK0955313T3 (pt) |
| EA (1) | EA000582B1 (pt) |
| ES (1) | ES2258774T3 (pt) |
| HU (1) | HU225424B1 (pt) |
| NO (1) | NO321153B1 (pt) |
| NZ (1) | NZ305472A (pt) |
| OA (1) | OA10528A (pt) |
| PL (1) | PL186518B1 (pt) |
| PT (1) | PT955313E (pt) |
| UA (1) | UA46767C2 (pt) |
| WO (1) | WO1996033215A1 (pt) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070166353A1 (en) * | 1988-04-08 | 2007-07-19 | Stryker Corporation | Osteogenic proteins |
| US6586388B2 (en) | 1988-04-08 | 2003-07-01 | Stryker Corporation | Method of using recombinant osteogenic protein to repair bone or cartilage defects |
| US20080233170A1 (en) * | 1992-02-21 | 2008-09-25 | Stryker Corporation | Osteogenic Proteins |
| ZA9711580B (en) * | 1996-12-25 | 1999-09-23 | Hoechst Marion Roussel Ltd | Process for the production of purified dimeric bone morphogenetic factors. |
| ES2244043T3 (es) * | 1997-01-30 | 2005-12-01 | Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh | Composicion liofilizada de mp52 humana de factor morfogenetico oseo. |
| AU6267798A (en) † | 1997-02-07 | 1998-08-26 | Stryker Corporation | Matrix-free osteogenic devices, implants and methods of use thereof |
| US6727224B1 (en) | 1999-02-01 | 2004-04-27 | Genetics Institute, Llc. | Methods and compositions for healing and repair of articular cartilage |
| KR100775958B1 (ko) | 2005-03-30 | 2007-11-13 | 김정문 | 조직재생 기능을 가지는 비활성 폴리펩티드 및 그 제조방법 |
| WO2006104306A1 (en) * | 2005-03-30 | 2006-10-05 | Jung Moon Kim | Non-activated polypeptides having a function of tissue regeneration and method for preparing the same |
| US20060286144A1 (en) * | 2005-06-17 | 2006-12-21 | Chunlin Yang | Reinforced collagen scaffold |
| PT1948689E (pt) | 2005-11-18 | 2012-05-09 | Bioph Biotech Entw Pharm Gmbh | Mutantes do fator de crescimento com atividade elevada |
| EP1880731A1 (en) * | 2006-07-18 | 2008-01-23 | BIOPHARM GESELLSCHAFT ZUR BIOTECHNOLOGISCHEN ENTWICKLUNG VON PHARMAKA mbH | Human growth and differentiation factor GDF-5 |
| AU2007234612B2 (en) * | 2006-12-14 | 2013-06-27 | Johnson & Johnson Regenerative Therapeutics, Llc | Protein stabilization formulations |
| US20100047299A1 (en) * | 2007-01-25 | 2010-02-25 | Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh | Use of gdf-5 for the improvement or maintenance of dermal appearance |
| US7678764B2 (en) | 2007-06-29 | 2010-03-16 | Johnson & Johnson Regenerative Therapeutics, Llc | Protein formulations for use at elevated temperatures |
| EP2019117A1 (en) | 2007-07-27 | 2009-01-28 | BIOPHARM GESELLSCHAFT ZUR BIOTECHNOLOGISCHEN ENTWICKLUNG VON PHARMAKA mbH | Optimized purification process of recombinant growth factor protein |
| JP5323832B2 (ja) | 2007-08-07 | 2013-10-23 | アドバンスト・テクノロジーズ・アンド・リジェネレイティブ・メディスン・エルエルシー | 酸性水溶液中にｇｄｆ−５を含むタンパク質製剤 |
| JP2009106163A (ja) * | 2007-10-26 | 2009-05-21 | Kyushu Univ | 核酸配列、ベクター、形質転換体、製造方法、及び、核酸配列プライマー |
| JP5599778B2 (ja) | 2008-04-14 | 2014-10-01 | デピュイ・シンセス・プロダクツ・エルエルシー | 液体緩衝ｇｄｆ−５製剤 |
| US9226898B1 (en) * | 2009-11-18 | 2016-01-05 | Richard C. K. Yen | Submicron particles for the treatment of radiation damage in patients |
| US11260110B2 (en) | 2009-11-18 | 2022-03-01 | Ptlnv, Llc, Series Four (4) | Nanoparticles for the therapeutic treatment of radiation-induced skin ulcers |
| US20130122066A1 (en) | 2010-07-30 | 2013-05-16 | Biopham Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh | Drug delivery devices and growth factor formulations for accelerated wound healing |
| US8551525B2 (en) | 2010-12-23 | 2013-10-08 | Biostructures, Llc | Bone graft materials and methods |
| US8398611B2 (en) | 2010-12-28 | 2013-03-19 | Depuy Mitek, Inc. | Compositions and methods for treating joints |
| US8455436B2 (en) | 2010-12-28 | 2013-06-04 | Depuy Mitek, Llc | Compositions and methods for treating joints |
| US8524662B2 (en) | 2010-12-28 | 2013-09-03 | Depuy Mitek, Llc | Compositions and methods for treating joints |
| EP2537538A1 (en) | 2011-06-22 | 2012-12-26 | Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka mbH | Bioresorbable Wound Dressing |
| US8623839B2 (en) | 2011-06-30 | 2014-01-07 | Depuy Mitek, Llc | Compositions and methods for stabilized polysaccharide formulations |
| EP2602264A1 (en) | 2011-12-05 | 2013-06-12 | Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka mbH | GDF-5 mutant for inducing cartilage formation |
| US9682099B2 (en) | 2015-01-20 | 2017-06-20 | DePuy Synthes Products, Inc. | Compositions and methods for treating joints |
| WO2021122545A1 (en) | 2019-12-18 | 2021-06-24 | Merck Patent Gmbh | Use of the gdf-5 mutant for the treatment of pain and cartilage destruction |
| KR20240064367A (ko) * | 2022-11-04 | 2024-05-13 | 주식회사 대웅제약 | TGF-β3 단백질의 정제방법 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4725234A (en) * | 1985-08-15 | 1988-02-16 | Ethridge Edwin C | Alveolar bone grafting process with controlled surface active ceramics |
| US5079352A (en) * | 1986-08-22 | 1992-01-07 | Cetus Corporation | Purified thermostable enzyme |
| US5354557A (en) * | 1988-04-08 | 1994-10-11 | Stryker Corporation | Osteogenic devices |
| GB8927546D0 (en) * | 1989-12-06 | 1990-02-07 | Ciba Geigy | Process for the production of biologically active tgf-beta |
| US5143829A (en) * | 1990-03-29 | 1992-09-01 | California Biotechnology Inc. | High level expression of basic fibroblast growth factor having a homogeneous n-terminus |
| US5118667A (en) * | 1991-05-03 | 1992-06-02 | Celtrix Pharmaceuticals, Inc. | Bone growth factors and inhibitors of bone resorption for promoting bone formation |
| US5171579A (en) * | 1991-10-11 | 1992-12-15 | Genetics Institute, Inc. | Formulations of blood clot-polymer matrix for delivery of osteogenic proteins |
| AU674500B2 (en) | 1991-11-04 | 1997-01-02 | Genetics Institute, Llc | Recombinant bone morphogenetic protein heterodimers, compositions and methods of use |
| ATE188996T1 (de) * | 1992-02-12 | 2000-02-15 | Bioph Biotech Entw Pharm Gmbh | Dna-sequenzen kodierend für neuartige wachstums- /differentierungsfaktoren |
| EP1439190A1 (en) | 1993-01-12 | 2004-07-21 | The Johns Hopkins University School Of Medicine | Growth differentiation factor-5 |
| IL110589A0 (en) * | 1993-08-10 | 1994-11-11 | Bioph Biotech Entw Pharm Gmbh | Growth/differentiation factor of the TGF- beta family |
| US6248554B1 (en) | 1993-11-24 | 2001-06-19 | The Procter & Gamble Company | DNA sequence coding for a BMP receptor |
| US5399677A (en) | 1993-12-07 | 1995-03-21 | Genetics Institute, Inc. | Mutants of bone morphogenetic proteins |
| DE69434651T2 (de) * | 1993-12-07 | 2007-03-08 | Genetics Institute, Inc., Cambridge | Bmp-12, bmp-13 und diese enthaltende sehne-induzierende zusammensetzungen |
| US5707962A (en) * | 1994-09-28 | 1998-01-13 | Gensci Regeneration Sciences Inc. | Compositions with enhanced osteogenic potential, method for making the same and therapeutic uses thereof |
-
1996
- 1996-04-19 US US08/945,459 patent/US7235527B2/en not_active Expired - Fee Related
- 1996-04-19 BR BR9608019-1A patent/BR9608019A/pt not_active IP Right Cessation
- 1996-04-19 NZ NZ305472A patent/NZ305472A/en not_active IP Right Cessation
- 1996-04-19 HU HU9801697A patent/HU225424B1/hu not_active IP Right Cessation
- 1996-04-19 DE DE69636728T patent/DE69636728T4/de not_active Expired - Lifetime
- 1996-04-19 EP EP96910198A patent/EP0955313B1/en not_active Expired - Lifetime
- 1996-04-19 UA UA97115563A patent/UA46767C2/uk unknown
- 1996-04-19 ES ES96910198T patent/ES2258774T3/es not_active Expired - Lifetime
- 1996-04-19 PL PL96322945A patent/PL186518B1/pl not_active IP Right Cessation
- 1996-04-19 AU AU53470/96A patent/AU704515C/en not_active Ceased
- 1996-04-19 WO PCT/JP1996/001062 patent/WO1996033215A1/ja not_active Ceased
- 1996-04-19 DE DE69636728A patent/DE69636728D1/de not_active Expired - Lifetime
- 1996-04-19 AT AT96910198T patent/ATE325131T1/de active
- 1996-04-19 PT PT96910198T patent/PT955313E/pt unknown
- 1996-04-19 EA EA199700329A patent/EA000582B1/ru not_active IP Right Cessation
- 1996-04-19 DK DK96910198T patent/DK0955313T3/da active
- 1996-04-19 CA CA002216741A patent/CA2216741C/en not_active Expired - Fee Related
-
1997
- 1997-10-17 OA OA70112A patent/OA10528A/en unknown
- 1997-10-17 NO NO19974812A patent/NO321153B1/no not_active IP Right Cessation
-
2003
- 2003-02-12 US US10/365,231 patent/US7268114B2/en not_active Expired - Fee Related
-
2007
- 2007-08-03 US US11/833,653 patent/US7816103B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9608019A (pt) | Uma nova proteína e um processo para a preparação da mesma' | |
| CN111944057B (zh) | 一种重组人胶原蛋白肽及其应用 | |
| Niyibizi et al. | Identification of the cartilage α 1 (XI) chain in type V collagen from bovine bone | |
| KR100214740B1 (ko) | 골유도조성물 | |
| DE69024261T2 (de) | Reinigung und Charakterisierung eines von einem Glioma abstammenden Wachstumsfaktors | |
| CA2000498C (en) | Osteogenic factors | |
| US4795804A (en) | Bone morphogenetic agents | |
| DE69936312T2 (de) | Mutanten von op-1 | |
| BRPI0109494B8 (pt) | muteína de fator viii, sequência de dna, vetor, processo para produção da muteína de fator viii, composição farmacêutica e uso da muteína do fator viii | |
| JP2004041236A (ja) | 骨形成具 | |
| RU99107759A (ru) | Применение антагонистов лептина для лечения резистентности к инсулину при диабете ii типа | |
| IE870535L (en) | Human endothelial cell growth factor | |
| BR9710665A (pt) | Compostos que promovem o desenvolvimento do tecido | |
| RU2180234C2 (ru) | Материалы, стимулирующие рост хряща/кости, для препарата | |
| BR9803960A (pt) | Gene de desidrogenase de d-sorbitol. | |
| CA2134030A1 (en) | Soluble interferon .alpha.-receptor, its preparation and use | |
| US5656737A (en) | DNA encoding macrophage migration inhibition factor from ocular lens | |
| SE9003887L (sv) | Cellproliferationsmatris och anvaendning daerav | |
| JP2002512018A (ja) | マトリックス結合因子 | |
| JPH02282396A (ja) | 再生骨髄から同定された骨形成成長ポリペプチド | |
| DE69130818T2 (de) | Chondromodulin-I-Protein | |
| EP1006125B1 (en) | Goat epididymal forward motility protein | |
| EP1357130A1 (en) | Basic fibroblastic growth factor with a specific collagen binding domain | |
| KR880701249A (ko) | 신규 단백질, 신경류킨 | |
| AU744514B2 (en) | Matrix binding factor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Transfer |
Free format text: HOECHST PHARMACEUTICALS & CHEMICALS K.K. (JP) |
|
| B25D | Requested change of name of applicant approved | ||
| B25A | Requested transfer of rights approved |
Free format text: BIOPHARM GESELLSCHAFT ZUR BIOTECHNOLOGISCHEN ENTWICKLUNG VON PHARMAKA MBH (DE) |
|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09S | Decision of refusal: publication cancelled [chapter 9.2.2 patent gazette] |
Free format text: ANULADA A PUBLICACAO DE INDEFERIMENTO POR TER SIDO INDEVIDA. |
|
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |